Graded review
The Sitting-Rising Test & Longevity: What the Evidence Actually Shows
The sitting-rising and sit-to-stand tests predict mortality in research — but they're markers of strength, balance, and flexibility, not a verdict.
Evidence scorecard
- What the sitting-rising test isMixed / emerging
- What the mortality study actually foundWell-supported
- The SRT is one of a whole family of "physical capability" testsThin / contested
- How to do it (and when not to)Mixed / emerging
- The part the headlines bury: it's modifiableMixed / emerging
- Where this fits in evidence-based longevityWell-supported
- The bottom lineMixed / emerging
If you have ever seen a headline claiming that how easily you get up off the floor predicts how long you'll live, you have met the sitting-rising test (SRT). It is a real, peer-reviewed measure, and the association with mortality is genuine — but the way it gets repackaged online ("this 30-second test reveals your lifespan") badly overstates what it can tell any one person. Here is what the science actually found, how to do the test, and — most importantly — why it is a marker of physical capability, not a crystal ball.
What the sitting-rising test is
The SRT was popularized by a 2012 study from a Brazilian research group led by Claudio Gil Araújo and Leonardo Brito1. The task is deceptively simple: from standing, lower yourself to a cross-legged seated position on the floor, then rise back to standing — using as little support as possible.
Scoring runs from 0 to 10. You start with 5 points for sitting down and 5 points for standing up (10 total). You lose one point each time you use a hand, forearm, knee, or the side of your leg for support, and half a point each time you become visibly unsteady. The final score is the sum of the sitting and rising halves1.
What makes the SRT interesting is that a single movement quietly taxes several things at once: lower-body and core strength, flexibility (especially hips and ankles), balance, and body composition. That is also why it correlates with so much — it is a composite of capabilities that all tend to decline together with age and inactivity.
What the mortality study actually found
In the original cohort, 2,002 adults aged 51–80 performed the SRT and were followed for a median of about 6.3 years, during which 159 (7.9%) died1. Lower scores tracked with higher all-cause mortality. After adjusting for age, sex, and body mass index, people in the lowest score band (0–3) had a hazard ratio of 5.44 versus the highest band (8–10), with intermediate bands at 3.44 and 1.84 — a clean dose-response gradient1. The authors estimated that each one-point increase in SRT score was associated with about a 21% improvement in survival1.
That sounds dramatic, and it is a real signal. But read the design carefully: this is an association in a retrospective cohort, adjusted for only three confounders. It tells you that, across a population, people who move well off the floor tend to outlive people who struggle — not that the test causes longevity, and not that any individual's score is a personal expiry date. People with low scores often have other things going on (obesity, cardiovascular disease, sedentary lifestyles, joint problems) that drive risk; the SRT is partly a convenient summary of those, not an independent oracle.
The SRT is one of a whole family of "physical capability" tests
The SRT did not come out of nowhere. It belongs to a large, much older body of research showing that simple measures of physical function predict survival — and that literature is what gives the idea credibility.
A landmark 2010 BMJ systematic review and meta-analysis pooled studies of grip strength, walking speed, chair-rise time, and standing balance, and found that across the board, weaker performance predicted higher mortality in community-dwelling adults2. The building blocks of that finding are themselves well known:
- Grip strength. In the international PURE study of nearly 140,000 people, each 5 kg drop in grip strength was associated with higher all-cause and cardiovascular mortality — grip was actually a stronger predictor of death than systolic blood pressure3.
- Gait speed. A pooled analysis of 34,485 older adults in JAMA showed that usual walking speed predicted survival across age and sex, with faster walkers living longer4.
- Cardiorespiratory fitness (VO2 max). The cardiovascular member of this family is arguably the best-studied of all — low fitness predicts mortality on par with smoking, and unlike the SRT it's measured on a treadmill rather than the floor (see VO2 max and longevity).
- The Short Physical Performance Battery (SPPB). This standardized battery — gait speed, balance, and a five-time chair-stand — was designed by Guralnik and colleagues and validated against later disability and death5. A 2016 meta-analysis confirmed that lower SPPB scores predict all-cause mortality6.
The closest clinical cousin to the SRT is the five-times sit-to-stand test (rise from a chair five times as fast as you can, no hands). It is a standard geriatric measure with published reference values by age and sex7, and it is one of the three components of the SPPB. Where the SRT uses the floor (demanding more flexibility and balance), the chair-stand isolates lower-body power and is easier to standardize — which is why clinicians tend to prefer it.
So the honest framing is: the SRT is a vivid, low-tech entry into a real and robust field. It is not a uniquely magical test, and it has not been validated as rigorously as gait speed or grip strength.
How to do it (and when not to)
If you want to try the SRT yourself, do it on a non-slip surface with clear space around you, ideally with someone nearby. Cross your legs, lower to a seated position, then stand back up, trying not to use your hands, knees, or furniture. Count the supports you used and any wobbles.
Skip it — or do a seated chair-stand instead — if you have knee, hip, or back problems, balance disorders, are pregnant, or are frail or at high fall risk. The test is only "safe" for people who are already reasonably mobile; for everyone else, the more useful and safer measure is the timed chair-stand or a clinician-administered SPPB. This is a screening prompt, not a diagnostic, and a low score is a reason to talk to a clinician, not to panic.
The part the headlines bury: it's modifiable
Here is the genuinely useful takeaway, and the reason the test matters at all. The qualities the SRT measures — strength, balance, flexibility, body composition — are among the most trainable things in the human body, at any age.
The classic demonstration is a 1990 JAMA study in which frail nursing-home residents in their 90s roughly doubled their muscle strength with eight weeks of supervised resistance training, with measurable gains in mobility9. And the LIFE study — a large randomized trial in sedentary older adults — showed that a structured physical-activity program meaningfully reduced the incidence of major mobility disability versus a health-education control8. In other words, the same low-tech capabilities that predict mortality are the ones that respond to exercise.
That flips the entire meaning of the SRT. A low score is not a prophecy — it is feedback. It points at a deficit (lower-body strength, hip and ankle mobility, balance) that strength training, mobility work, and simply moving more can improve — and that a cheap, well-evidenced training amplifier like creatine for aging can help you build on faster. Whether improving your SRT score causally extends your life has not been proven by a randomized trial; what has been shown is that the underlying capabilities are trainable and that training reduces disability. That is a much more honest — and more actionable — claim than "this test predicts your death."
Where this fits in evidence-based longevity
Functional tests like the SRT sit alongside lab-based measures in the longevity-assessment toolkit. They are cheap, fast, and capture something blood panels miss — how well your body actually moves and holds together. For the broader, honest picture of what longevity medicine can and can't deliver, see our pillar on the evidence behind longevity medicine. For the lab side of assessment, compare against what longevity biomarker panels actually measure and the accuracy of biological-age and epigenetic-clock tests. And if you're weighing whether to involve a clinician in any of this, our explainer on what a longevity doctor is (and whether you need one) is the place to start. If you want to see how the providers offering this kind of structured assessment compare on oversight, evidence honesty, and price, we grade the field in our best longevity clinics hub.
The bottom line
The sitting-rising test is a legitimate, peer-reviewed marker that belongs to a deep literature on physical capability and survival — alongside grip strength, gait speed, and the chair-stand. Lower scores genuinely track with higher mortality. But it is an association and a screen, not a verdict: it summarizes strength, balance, and flexibility, much of which is downstream of other health conditions and all of which is trainable. Treated as a number that reveals your lifespan, it's hype. Treated as a quick, honest read on a part of your health you can actually improve, it's useful.
Frequently asked questions
Does the sitting-rising test really predict how long you'll live?
It predicts mortality at the population level: in the original 2,002-person study, lower scores were associated with higher all-cause mortality, and each one-point gain tracked with about a 21% better survival. But it's an association adjusted for only age, sex, and BMI — a marker of strength, balance, and flexibility, not a personal verdict or expiry date.
What's a good sitting-rising test score?
Scores run 0 to 10. In the research, people scoring 8–10 (rising with little or no support) had the lowest mortality risk, while those scoring 0–3 had the highest. A score below 8 simply flags room to improve lower-body strength, mobility, and balance — not a diagnosis.
Is the sitting-rising test the same as the sit-to-stand test?
They're cousins. The sitting-rising test uses the floor, demanding more flexibility and balance. The five-times sit-to-stand test (rising from a chair five times, no hands) is the standardized clinical version and one of three components of the Short Physical Performance Battery used in geriatrics.
Can I improve my sitting-rising test score?
Yes — that's the useful part. The qualities it measures are highly trainable at any age. Resistance training has roughly doubled muscle strength even in people in their 90s, and structured activity programs reduce mobility disability. A low score is feedback to act on, not a fixed outcome.
References
- Brito LB, Ricardo DR, Araújo DS, Ramos PS, Myers J, Araújo CG (2014). Ability to sit and rise from the floor as a predictor of all-cause mortality.. European Journal of Preventive Cardiology. https://pubmed.ncbi.nlm.nih.gov/23242910/
- Cooper R, Kuh D, Hardy R; Mortality Review Group (2010). Objectively measured physical capability levels and mortality: systematic review and meta-analysis.. BMJ. https://pubmed.ncbi.nlm.nih.gov/20829298/
- Leong DP, Teo KK, Rangarajan S, et al. (2015). Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study.. Lancet. https://pubmed.ncbi.nlm.nih.gov/25982160/
- Studenski S, Perera S, Patel K, et al. (2011). Gait speed and survival in older adults.. JAMA. https://pubmed.ncbi.nlm.nih.gov/21205966/
- Guralnik JM, Simonsick EM, Ferrucci L, et al. (1994). A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.. Journal of Gerontology. https://pubmed.ncbi.nlm.nih.gov/8126356/
- Pavasini R, Guralnik J, Brown JC, et al. (2016). Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis.. BMC Medicine. https://pubmed.ncbi.nlm.nih.gov/28003033/
- Bohannon RW (2006). Reference values for the five-repetition sit-to-stand test: a descriptive meta-analysis of data from elders.. Perceptual and Motor Skills. https://pubmed.ncbi.nlm.nih.gov/17037663/
- Pahor M, Guralnik JM, Ambrosius WT, et al. (LIFE study investigators) (2014). Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial.. JAMA. https://pubmed.ncbi.nlm.nih.gov/24866862/
- Fiatarone MA, Marks EC, Ryan ND, et al. (1990). High-intensity strength training in nonagenarians. Effects on skeletal muscle.. JAMA. https://pubmed.ncbi.nlm.nih.gov/2342214/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
More graded reviews
Longevity Medicine: What's Proven vs Hyped
An honest, evidence-graded tour of the longevity toolkit — what has human outcome RCTs versus what is animal or mechanistic-only.
ReadDo NAD+ and Peptides Actually Extend Lifespan?
NAD+ precursors reliably raise NAD+ but show modest, mixed human outcomes. Peptides and growth hormone carry real cautions. An honest evidence review.
ReadRapamycin & Metformin for Longevity: The Evidence
Strong animal data, a glaring human RCT gap. What the PEARL pilot, the TAME rationale, and metformin's observational signal really show.
ReadAre Longevity Clinics Worth It?
DTC and IV longevity clinics sit on the weakest evidence in the field. What a critical review found, and how to vet a provider before paying.
ReadRapamycin for Longevity: Hype vs Evidence
Rapamycin is the most reproducible lifespan extender in mice — but there is no human longevity trial. An honest split of the hype from the evidence.
ReadWhat the PEARL Trial Actually Showed About Rapamycin
PEARL was the largest decentralized RCT of rapamycin in healthy aging — and it missed its primary endpoint. An honest readout of what it did and didn't prove.
ReadLongevity Clinics vs Lab Memberships vs Rx Telehealth: What Each Delivers
The longevity market splits into four bands: concierge clinics, membership programs, DTC labs, single-product Rx. What each delivers, and who it's for.
ReadBiological Age Tests: Do Epigenetic Clocks Actually Work?
Epigenetic clocks (Horvath, GrimAge, DunedinPACE) predict aging well in populations — but are noisy and unproven for individuals. An honest evidence review.
ReadNAD+ for Longevity: What the Trials Actually Show
NR and NMN reliably raise NAD+ in humans, but the trials mostly fail to show clinical or longevity outcomes. An honest review of the hype versus the data.
ReadWhat Do Longevity Biomarker Panels Actually Test?
Longevity panels mix genuinely useful, outcome-validated markers (ApoB, HbA1c, hs-CRP) with vanity numbers. An honest, evidence-graded breakdown.
ReadGLP-1s for Healthspan & Longevity: The Evidence
GLP-1 drugs have the strongest human outcome data in longevity — but it's cardiometabolic risk reduction, not proven lifespan extension. An honest review.
ReadPeptides for Longevity: What's Real and What's Marketing
Most longevity peptides are sold on mechanism and anecdote, not human outcomes. An honest, citation-backed review of what the evidence actually supports.
ReadMetformin for Longevity: The TAME Trial Evidence
Metformin's anti-aging case is mechanistic and observational — no completed RCT proves it. Why the TAME trial exists, and the exercise caveat.
ReadConcierge vs Membership Longevity: What You Actually Get
Concierge clinics ($8k–$25k/yr) sell diagnostics; membership programs ($99–$300/mo) sell ongoing treatment. What each delivers, and where the money goes.
ReadHow We Grade Longevity Providers: Our Methodology
The five-axis rubric behind our longevity provider rankings: oversight, evidence honesty, transparency, price, and conflicts of interest.
ReadBest Longevity Supplements, Rated by Evidence (2026)
We grade the popular longevity supplements — NMN, NR, spermidine, resveratrol, CoQ10, omega-3, vitamin D, fisetin, GlyNAC — on human evidence, not hype.
ReadWhat Is a Longevity Doctor (and Do You Need One)?
A longevity doctor blends preventive medicine, biomarker testing, and lifestyle coaching. What they really do, credentials to check, and who needs one.
ReadSpermidine for Longevity: What the Evidence Shows
Spermidine induces autophagy and dietary intake tracks with lower mortality — but the best human trial was negative. An honest, evidence-graded review.
ReadHow Much Does a Longevity Clinic Cost?
Longevity care runs from ~$200/yr lab memberships to $20k+ concierge programs. A 2026 price-band guide to what each tier buys — and what's worth paying for.
ReadFree Biological-Age Tests & Calculators: Do They Actually Work?
Free biological-age calculators range from validated (PhenoAge from a basic blood panel) to entertainment. An honest guide to what's worth your time.
ReadTaurine for Longevity: Does the 2023 Science Study Hold Up?
A 2023 Science paper called taurine deficiency a driver of aging. A 2025 Science follow-up questioned its core premise. An honest, evidence-graded review.
ReadUrolithin A (Mitopure): Mitochondrial Hype or Real?
Urolithin A (Mitopure) has the cleanest human-trial record of any mitochondrial supplement — modest muscle gains in RCTs. But healthspan isn't lifespan.
ReadFisetin as a Senolytic: What "Hit-and-Run" Dosing Shows
Fisetin was the standout senolytic flavonoid in mouse screens and extended lifespan ~10%. In humans, the longevity data are essentially zero. An honest review.
ReadGlyNAC (Glycine + NAC) for Aging: What the Baylor Trials Actually Show
Baylor RCTs report GlyNAC corrects glutathione deficiency and several aging hallmarks in older adults. But the trials are small and the headlines overstate it.
ReadAlpha-Ketoglutarate (Rejuvant/AKG): Does the "8 Years Younger" Claim Hold Up?
The viral "8 years younger" AKG result came from a 42-person study with no placebo group and an unvalidated aging clock. An honest evidence review.
ReadDasatinib + Quercetin: How Far Along Is the Flagship Senolytic?
Dasatinib + quercetin is the first-in-human senolytic — with small IPF and kidney signals. But it's a chemo drug plus a flavonoid, with no longevity RCT yet.
ReadTruDiagnostic TruAge Review: Is the $229 Epigenetic Clock Worth It?
TruDiagnostic's TruAge uses the well-validated DunedinPACE clock — but no test proves the score predicts YOUR outcomes. An honest, evidence-graded review.
ReadFunction Health Review: Are 100+ Biomarkers Worth $499/yr?
Function Health's 100+ lab membership surfaces real outcome-validated markers — but roughly half are basic labs, and it tests without treating. Honest review.
ReadBryan Johnson's Blueprint Review: Evidence vs N-of-1 Hype
Bryan Johnson's Blueprint is a single-subject experiment with no control group — and roughly 90% of its likely benefit is replicable diet, sleep, and exercise.
ReadVO2 Max and Longevity: The Strongest Fitness Predictor of Lifespan
Cardiorespiratory fitness is one of the best-validated predictors of mortality — low fitness carries risk on par with smoking, and it's trainable.
ReadGrip Strength as a Longevity Biomarker: What the Evidence Shows
In the 140,000-person PURE study, grip strength outpredicted systolic blood pressure for mortality. A genuinely strong, free, at-home biomarker.
ReadFasting-Mimicking Diet (ProLon) Review: Does the Evidence Hold Up?
ProLon's 5-day fasting-mimicking diet has real human trials behind it — but most are tied to its inventor's company. An honest, graded look.
ReadHyperbaric Oxygen for Aging: Does the Telomere Claim Hold Up?
One small Israeli trial reported HBOT lengthened telomeres 38% and cut senescent cells. It's striking, unreplicated, and expensive. An honest, graded review.
ReadCreatine for Aging: The Cheapest Evidence-Backed Supplement?
Creatine has the strongest human evidence of any longevity supplement — for healthspan, not lifespan. With resistance training it adds muscle and strength.
ReadThe Hallmarks of Aging, Explained (and Why They Matter)
The hallmarks of aging are the cellular processes that drive getting old. A plain-English guide to the 2013 and 2023 framework — and why each one gets targeted.
ReadSulforaphane for Longevity: Promising Biology, Preclinical Proof
Sulforaphane from broccoli extends lifespan in worms and activates Nrf2 — but the human longevity evidence is preclinical. An honest, evidence-graded review.
ReadGlycine for Longevity: The Other Half of GlyNAC
Glycine alone extended mouse lifespan ~6% in the ITP. But the dramatic 'reverses aging' results belong to the GlyNAC combo, not solo glycine. An honest review.
ReadMicrodose Lithium for Longevity & Brain Aging: The Evidence
A 2025 Nature study tied lithium deficiency to Alzheimer's in mice. But that's mouse healthspan, not human lifespan — and lithium has a narrow safety window.
ReadErgothioneine: The "Longevity Vitamin"? An Evidence-Graded Review
Ergothioneine has a strong observational link to lower mortality — but no human trial, and the signal may just track a healthy diet. An honest grade.
ReadOmega-3 for Longevity: What the DO-HEALTH Trial Actually Shows
DO-HEALTH found 1 g/day omega-3 slowed epigenetic clocks by ~3–4 months. Real, randomized — but a small, surrogate effect. An honest evidence grade.
ReadCoQ10 & Ubiquinol for Aging: What the Evidence Actually Shows
KiSel-10 showed CoQ10 plus selenium cut cardiovascular mortality in elderly Swedes — but the benefit is CV-specific, not lifespan. An honest grade.
ReadBest Epigenetic Clock: GrimAge vs PhenoAge vs DunedinPACE
GrimAge predicts mortality, PhenoAge predicts disease, DunedinPACE measures pace of aging. No clock is validated to guide your treatment. An honest comparison.
ReadGlycanAge Review: Is the Glycan Aging Test Worth It?
GlycanAge measures IgG glycans tied to inflammation, and they move with lifestyle — but independent validation is thin and it can't localize a problem. Graded.
ReadGalleri Multi-Cancer Test Review: Is It Worth It?
Galleri's blood test can flag a cancer signal across many types — but no trial shows it saves lives, and false positives trigger costly cascades. Graded.
ReadFountain Life vs Human Longevity Inc: MRI Clinics Compared
Two whole-body-MRI longevity clinics compared. The headline isn't the price — it's the incidentaloma problem: most scary scan findings turn out to be nothing.
ReadSauna & Longevity: What the Finnish Studies Actually Show
Frequent sauna use is tied to ~40% lower all-cause mortality in Finnish men — but it's one observational cohort, not a randomized trial. An honest grade-B read.
ReadCold Plunge for Longevity: Hype vs Evidence
Cold exposure extends lifespan in worms and flies — but there's zero human lifespan data, and the human evidence is about recovery and mood, not living longer.
ReadZone 2 Training for Longevity: The Evidence, Graded Honestly
Zone 2 has a strong mitochondrial mechanism and builds the fitness that predicts lifespan — but no trial proves Zone 2 itself extends life. Graded honestly.
ReadOutlive by Peter Attia: An Evidence-Based Review
Attia's Outlive popularized Medicine 3.0 and the Four Horsemen. We grade the framework honestly: where the evidence is strong, and where it's reasoned opinion.
ReadBest Longevity Blood Test Services, Compared (2026)
Function, InsideTracker, Lifeforce, Superpower — graded honestly. The four cheap outcome-validated markers matter; the '100+ biomarker' count mostly doesn't.
ReadBest At-Home Biological Age Test (2026): Honestly Graded
Blood-methylation clocks are the only defensible at-home bio-age tier; saliva and telomere kits are noisier. None proves you're aging slower. Honestly graded.
ReadInsideTracker Review: Worth It in 2026?
InsideTracker adds DNA and an 'InnerAge' score to blood panels. The core markers are real, but it's pricier per marker and recommendations skew to upsells.
ReadLifeforce Review: Is the Membership Worth It?
Lifeforce bundles a clinician and Rx onto a ~50-marker quarterly panel for ~$129/mo. That crosses test-into-treat — but the panel is narrow and the upsell real.
ReadDoes Resveratrol Actually Work for Longevity?
A skeptical, evidence-graded review: the SIRT1 story was an artifact, a 2025 primate trial found no lifespan benefit, and oral resveratrol barely reaches cells.
ReadCollagen for Aging: What the Evidence Says
Industry-funded trials show skin and joint benefits; independent reviews are cautious. Collagen digests to amino acids, and the longevity claim is unproven.
ReadQuercetin for Longevity: Senolytic Hype vs Evidence
Quercetin's senolytic effect needs the dasatinib combination. Standalone quercetin has no human senolytic evidence — just modest anti-inflammatory effects.
ReadSuperpower Health Review: Is the $499 100-Lab Membership Worth It?
Superpower's $499/yr 100+ lab membership is slick and cheap-per-marker — but it tests without treating, and the panel leans on padding. Honest, graded review.
ReadFunction Health vs Superpower: Which Lab Membership Wins?
Function Health vs Superpower, graded honestly: nearly identical 100+ lab memberships that both test without treating. The tiebreaker isn't the marker count.
ReadNOVOS Core Review: Does the 12-Ingredient Longevity Drink Work?
NOVOS Core bundles 12 longevity ingredients into one daily drink. The formulation logic is real; the human lifespan proof isn't. An honest, graded review.
ReadTally Health Review: Is the TruAge Epigenetic Membership Worth It?
Tally Health pairs a TruAge epigenetic-age test with coaching and a supplement. The clock is real science; tracking your own aging with it isn't proven.
ReadNOVOS vs Tally Health: Which Longevity Brand Is Worth It?
NOVOS sells a multi-pathway longevity supplement; Tally Health sells an epigenetic-age test plus its own pill. A graded, honest head-to-head on what's proven.
ReadSpermidine vs Fisetin: Two Longevity Supplements, Honestly Compared
Spermidine targets autophagy; fisetin clears senescent cells. Different mechanisms, different evidence grades — an honest, head-to-head longevity comparison.
ReadFunction Health vs InsideTracker: Which Lab-Test Membership Wins?
Function casts a wide 100+ marker net; InsideTracker pairs fewer markers with an algorithm. We grade breadth, actionability, price — and who each fits.
ReadGlycine vs GlyNAC: Is Adding NAC Worth It for Longevity?
GlyNAC adds N-acetylcysteine to glycine for glutathione restoration. Is the extra ingredient worth it for longevity? An honest, graded comparison.
ReadAcarbose for Longevity: The Strongest Mouse Drug You've Never Heard Of
Acarbose robustly extended mouse lifespan in the NIA's rigorous ITP — better replicated than most longevity drugs. But there are zero human longevity trials.
ReadIntermittent Fasting for Longevity: What the Human Trials Actually Show
Time-restricted eating and 5:2 have strong animal data — but human trials show the benefit is mostly about eating less, not the clock. No lifespan proof.
ReadBerberine for Longevity: Nature's Metformin, or Marketing?
Berberine activates AMPK like metformin and lowers glucose and lipids in humans — but its longevity evidence is animal-only. An honest look at the hype.
Read